Morgan Stanley

SEC CIK: 0000895421
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

RYZB holding history

RayzeBio, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RYZB overview All 13F holders of RYZB Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2023

Holdings of RYZB by Morgan Stanley, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−194,151−100.0%	Sold out	Holders
Q4 2023	194,151	$12.1M	<0.1%	+182,856+1,618.9%	Added	Holders
Q3 2023	11,295	$250.7K	<0.1%	+11,295	New	Holders